FMC (NYSE:FMC) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at ...

Fintel reports that on February 5, 2025, RBC Capital downgraded their outlook for FMC (NYSE:FMC) from Outperform to Sector ...

Fintel reports that on February 5, 2025, RBC Capital upgraded their outlook for SSR Mining (NasdaqGS:SSRM) from Underperform ...

RBC Capital analyst Ashish Sabadra maintained a Buy rating on Moody’s (MCO – Research Report) on February 4 and set a price target of $550.00.

RBC Capital analyst Ashish Sabadra maintained a Buy rating on S&P Global (SPGI – Research Report) on February 4 and set a price target of ...

Find insight on TotalEnergies, oil and natural gas futures, and more in the latest Market Talks covering Energy and Utilities ...

The stock market extended its winning streak on Wednesday, closing firmer as investors seemed to have already priced in the ...

SmartCentres Real Estate Investment Trust ("SmartCentres” or the "Trust”) (TSX:SRU.UN) announced today that it has closed its ...

Oxford, UK - 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the ...

Base Metal Prices Mixed as Trade Tensions Continue to Unnerve Market -- Market Talk 0950 GMT - Base metal prices are mixed, with LME three-month copper flat at $9,174 a metric ton and LME three-month ...

RBC Capital Mkts has recently raised SAGE Therapeutics Inc (SAGE) stock to Sector Perform rating, as announced on November 21, 2024, according to Finviz. Earlier, on October 10, 2 ...

Neumora Therapeutics Inc (NMRA) stock saw a modest uptick, ending the day at $1.91 which represents a slight increase of $0.05 or 2.69% from the prior close of $1.86. The stock opened at $1.87 and ...